Kymera Therapeutics (KYMR) News Today → War Over Taiwan? Protect Your Wealth NOW (From Behind the Markets) (Ad) Free KYMR Stock Alerts $34.03 +0.68 (+2.04%) (As of 01:10 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineKymera Therapeutics (KYMR) Scheduled to Post Quarterly Earnings on Thursdaymarketbeat.com - April 26 at 11:03 AMKymera Therapeutics to Report First Quarter 2024 Financial Results on May 2globenewswire.com - April 25 at 7:00 AMKymera Therapeutics stock gets Outperform rating on positive outlookinvesting.com - April 24 at 9:44 AMCommit To Buy Kymera Therapeutics At $17.50, Earn 9% Annualized Using Optionsnasdaq.com - April 24 at 9:44 AMOppenheimer Initiates Coverage of Kymera Therapeutics (KYMR) with Outperform Recommendationmsn.com - April 23 at 7:36 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Consensus Rating of "Moderate Buy" from Analystsamericanbankingnews.com - April 23 at 4:26 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Rating of "Moderate Buy" from Analystsmarketbeat.com - April 23 at 4:26 AMKymera Therapeutics (NASDAQ:KYMR) Receives New Coverage from Analysts at Oppenheimeramericanbankingnews.com - April 23 at 3:34 AMKymera Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)benzinga.com - April 22 at 10:22 AMOppenheimer Begins Coverage on Kymera Therapeutics (NASDAQ:KYMR)marketbeat.com - April 22 at 8:29 AMKymera Therapeutics (NASDAQ:KYMR) Stock Price Up 4.5%marketbeat.com - April 18 at 4:55 PMShort Interest in Kymera Therapeutics, Inc. (NASDAQ:KYMR) Increases By 8.8%americanbankingnews.com - April 16 at 1:26 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Sees Significant Growth in Short Interestmarketbeat.com - April 15 at 11:14 PMResearch Analysts Offer Predictions for Kymera Therapeutics, Inc.'s Q1 2024 Earnings (NASDAQ:KYMR)marketbeat.com - April 11 at 7:26 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Holdings Lifted by Vanguard Group Inc.marketbeat.com - April 9 at 4:08 AMKymera Therapeutics, Inc.: Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meetingfinanznachrichten.de - April 8 at 3:55 PMKymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meetingglobenewswire.com - April 8 at 7:00 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Receives Average Rating of "Moderate Buy" from Brokeragesmarketbeat.com - March 29 at 4:26 AMKymera Therapeutics Inc (KYMR)investing.com - March 28 at 12:07 AMKYMR May 2024 30.000 callfinance.yahoo.com - March 20 at 6:44 AMKYMR Aug 2024 20.000 putfinance.yahoo.com - March 19 at 9:58 PMBiotech upgrades to new Watertown digs with triple the spacebizjournals.com - March 18 at 10:12 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Director Bruce Booth Sells 71,764 Sharesinsidertrades.com - March 16 at 8:16 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Major Shareholder Venture Fund X. L.P. Atlas Sells 42,302 Sharesinsidertrades.com - March 14 at 9:20 AMGSA Capital Partners LLP Has $710,000 Stock Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)marketbeat.com - March 13 at 5:33 AMKymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meetingglobenewswire.com - March 8 at 10:00 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Bought by Fmr LLCmarketbeat.com - March 7 at 4:39 AMUBS Group AG Decreases Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)marketbeat.com - March 6 at 4:24 AMInsider Sell: CFO Bruce Jacobs Sells 3,934 Shares of Kymera Therapeutics Inc (KYMR)finance.yahoo.com - March 5 at 10:57 AMAnalysts' Revenue Estimates For Kymera Therapeutics, Inc. (NASDAQ:KYMR) Are Surging Higherfinance.yahoo.com - March 3 at 9:41 AMKymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $54.00 at Truist Financialmarketbeat.com - March 1 at 9:16 AMProfund Advisors LLC Cuts Holdings in Kymera Therapeutics, Inc. (NASDAQ:KYMR)marketbeat.com - March 1 at 6:26 AMKymera Therapeutics, Inc. (NASDAQ:KYMR) Shares Bought by Dark Forest Capital Management LPmarketbeat.com - February 29 at 5:47 AMKymera Therapeutics to Participate in Upcoming March Investor Conferencesglobenewswire.com - February 28 at 7:00 AMPiper Sandler Keeps Their Buy Rating on Kymera Therapeutics (KYMR)markets.businessinsider.com - February 27 at 3:13 PMPiper Sandler Maintains Overweight Rating for Kymera Therapeutics: Here's What You Need To Knowmarkets.businessinsider.com - February 27 at 3:13 PMKymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $56.00 at Piper Sandlermarketbeat.com - February 27 at 10:58 AMKymera Therapeutics (NASDAQ:KYMR) Hits New 1-Year High After Analyst Upgrademarketbeat.com - February 26 at 10:31 AMMaintaining Hold on Kymera Therapeutics Amidst Promising Pipeline and Industry Challengesmarkets.businessinsider.com - February 26 at 9:02 AMAlgert Global LLC Purchases 72,802 Shares of Kymera Therapeutics, Inc. (NASDAQ:KYMR)marketbeat.com - February 26 at 7:32 AMEarnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming Their Forecastsfinance.yahoo.com - February 24 at 1:50 PMKymera Therapeutics Stock (NASDAQ:KYMR) Dividends: History, Yield and Datesbenzinga.com - February 24 at 8:49 AMBreaking Down Kymera Therapeutics: 4 Analysts Share Their Viewsmarkets.businessinsider.com - February 23 at 7:54 PMStifel Nicolaus Reaffirms Their Buy Rating on Kymera Therapeutics (KYMR)markets.businessinsider.com - February 23 at 2:54 PMKymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 23 at 2:54 PMKymera Therapeutics (NASDAQ:KYMR) Price Target Raised to $47.00marketbeat.com - February 23 at 1:34 PMKymera Therapeutics (NASDAQ:KYMR) Posts Earnings Resultsmarketbeat.com - February 23 at 12:53 PMAnalysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR) and Morphic Holding (MORF)markets.businessinsider.com - February 23 at 12:39 AMQ4 2023 Kymera Therapeutics Inc Earnings Callfinance.yahoo.com - February 23 at 12:39 AMKymera Therapeutics, Inc.: Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Updatefinanznachrichten.de - February 22 at 9:39 AM Get Kymera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KYMR and its competitors with MarketBeat's FREE daily newsletter. Email Address War Over Taiwan? Protect Your Wealth NOW (Ad)With tensions rapidly escalating, Taiwan could provide the spark at any moment. Don't let your financial future get caught in the crossfire unprepared. Access my report now >>> KYMR Media Mentions By Week KYMR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KYMR News Sentiment▼0.390.33▲Average Medical News Sentiment KYMR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KYMR Articles This Week▼113▲KYMR Articles Average Week Get Kymera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KYMR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VCEL News Today DNLI News Today CGON News Today BEAM News Today DNA News Today TWST News Today FUSN News Today RXRX News Today SANA News Today NMRA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KYMR) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kymera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
